Viewing Study NCT00281827


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-03-10 @ 7:35 AM
Study NCT ID: NCT00281827
Status: TERMINATED
Last Update Posted: 2017-12-28
First Post: 2006-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the lung View
None squamous cell lung cancer View
None large cell lung cancer View
None stage II non-small cell lung cancer View
None stage IIIA non-small cell lung cancer View